The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic by Frankell, AM, Jammula, S, Li, X, Contino, G, Killcoyne, S, Abbas, S, Perner, J, Bower, L, Devonshire, G, Ococks, E, Grehan, N, Mok, J, O'Donovan, M, Macrae, S, Eldridge, MD, Tavaré, S, Oesophageal Cancer Clinical And Molecular Stratification (OCCAMS) Consortium, Fitzgerald, RC, Crichton, C

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics by Li, X, Francies, H, Secrier, M, Perner, J, Miremadi, A, Galeano-Dalmau, N, Barendt, W, Letchford, L, Leyden, G, Goffin, E, Barthorpe, A, Lightfoot, H, Chen, E, Gilbert, J, Noorani, A, Devonshire, G, Bower, L, Grantham, A, Macrae, S, Grehan, N, Wedge, D, Fitzgerald, R, Garnett, M